Kim AY, Hepatitis B, Virus, Coinfection HIV. Fibrosis, fat, and future directions. Am J Gastroenterol. 2019;114:710–2.

Article  PubMed  Google Scholar 

Xu M, Warner C, Duan X, Cheng Z, Jeyarajan AJ, Li W, Wang Y, et al. HIV coinfection exacerbates HBV-induced liver fibrogenesis through a HIF-1alpha- and TGF-beta1-dependent pathway. J Hepatol. 2024;80:868–81.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Corcorran MA, Kim N. Chronic hepatitis B and HIV coinfection. Top Antivir Med. 2023;31:14–22.

PubMed  PubMed Central  Google Scholar 

Klein MB, Althoff KN, Jing Y, Lau B, Kitahata M, Lo Re V 3rd, et al. Risk of end-stage liver disease in HIV-viral hepatitis coinfected persons in North America from the early to modern antiretroviral therapy eras. Clin Infect Dis. 2016;63:1160–7.

Article  PubMed  PubMed Central  Google Scholar 

Sterling RK, King WC, Khalili M, Chung RT, Sulkowski M, Jain MK, et al. A prospective study evaluating changes in histology, clinical and virologic outcomes in HBV-HIV co-infected adults in North America. Hepatology. 2021;74:1174–89.

Article  CAS  PubMed  Google Scholar 

Cervo A, Shengir M, Patel K, Sebastiani G. NASH in HIV. Curr HIV AIDS Rep. 2020;17:601–14.

Article  PubMed  Google Scholar 

Guaraldi G, Lonardo A, Maia L, Palella FJ. Jr. Metabolic concerns in aging HIV-infected persons: from serum lipid phenotype to fatty liver. AIDS. 2017;31(Suppl 2):S147–56.

Article  PubMed  Google Scholar 

Cai J, Sebastiani GHIV, Elevated Transaminases. Fatty liver: the perfect storm?? J Acquir Immune Defic Syndr. 2019;81:e23–5.

Article  PubMed  Google Scholar 

Gawrieh S, Vilar-Gomez E, Woreta TA, Lake JE, Wilson LA, Price JC, et al. Prevalence of steatotic liver disease, MASLD, MetALD and significant fibrosis in people with HIV in the united states. Aliment Pharmacol Ther. 2024;59:666–79.

Article  CAS  PubMed  Google Scholar 

Sebastiani G, Cinque F, Cascio A, Rockstroh JK, Guaraldi G. Inclusive healthcare in light of the new MASLD guidelines: should people living with HIV be screened for liver fibrosis? J Hepatol. 2025;82:e18-20.

Article  PubMed  Google Scholar 

Khalili M, King WC, Kleiner DE, Jain MK, Chung RT, Sulkowski M, Lisker-Melman M, et al. Fatty liver disease in a prospective North American cohort of adults with human immunodeficiency virus and hepatitis B virus coinfection. Clin Infect Dis. 2021;73:e3275–85.

Article  CAS  PubMed  Google Scholar 

Ko HH, Patel NH, Haylock-Jacobs S, Doucette K, Ma MM, Cooper C, et al. Severe hepatic steatosis is associated with low-level viremia and advanced fibrosis in patients with chronic hepatitis B in North America. Gastro Hep Advances. 2022;1(1):106–16.

Article  PubMed  PubMed Central  Google Scholar 

Sterling RK, Patel K, Duarte-Rojo A, Asrani SK, Alsawas M, Dranoff JA, et al. Aasld practice guideline on blood-based noninvasive liver disease assessment of hepatic fibrosis and steatosis. Hepatology. 2025;81(1):321–57.

Article  PubMed  Google Scholar 

Patel K, Asrani SK, Fiel MI, Levine D, Leung DH, Duarte-Rojo A, et al. Accuracy of blood-based biomarkers for staging liver fibrosis in chronic liver disease: a systematic review supporting the AASLD practice guideline. Hepatology. 2024. https://doi.org/10.1097/HEP.0000000000000842.

Article  PubMed  Google Scholar 

Matta B, Lee TH, Patel K. Use of non-invasive testing to stage liver fibrosis in patients with HIV. Curr HIV AIDS Rep. 2016;13:279–88.

Article  PubMed  Google Scholar 

Patel K, Sebastiani G. Limitations of non-invasive tests for assessment of liver fibrosis. JHEP Reports. 2020;2:100067.

Article  PubMed  PubMed Central  Google Scholar 

Sanyal AJ, Castera L, Wong VW. Noninvasive assessment of liver fibrosis in NAFLD. Clin Gastroenterol Hepatol. 2023;21:2026–39.

Article  CAS  PubMed  Google Scholar 

Bottero J, Lacombe K, Guechot J, Serfaty L, Miailhes P, Bonnard P, et al. Performance of 11 biomarkers for liver fibrosis assessment in HIV/HBV co-infected patients. J Hepatol. 2009;50:1074–83.

Article  CAS  PubMed  Google Scholar 

Sterling RK, King WC, Wahed AS, Kleiner DE, Khalili M, Sulkowski M, et al. Evaluating noninvasive markers to identify advanced fibrosis by liver biopsy in HBV/HIV co-infected adults. Hepatology. 2020;71:411–21.

Article  CAS  PubMed  Google Scholar 

European Association for Study of L. Asociacion Latinoamericana Para El estudio Del H. EASL-ALEH clinical practice guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis. J Hepatol. 2015;63:237–64.

Article  Google Scholar 

Bera C, Hamdan-Perez N, Patel K. Non-invasive assessment of liver fibrosis in hepatitis B patients. J Clin Med. 2024;13(4):1046. https://doi.org/10.3390/jcm13041046

Article  PubMed  PubMed Central  Google Scholar 

Miailhes P, Pradat P, Chevallier M, Lacombe K, Bailly F, Cotte L, Trabaud MA, et al. Proficiency of transient elastography compared to liver biopsy for the assessment of fibrosis in HIV/HBV-coinfected patients. J Viral Hepat. 2011;18:61–9.

Article  CAS  PubMed  Google Scholar 

Kim WR, Berg T, Asselah T, Flisiak R, Fung S, Gordon SC, et al. Evaluation of APRI and FIB-4 scoring systems for non-invasive assessment of hepatic fibrosis in chronic hepatitis B patients. J Hepatol. 2016;64:773–80.

Article  CAS  PubMed  Google Scholar 

Boyd A, Lasnier E, Molina JM, Lascoux-Combe C, Bonnard P, Miailhes P, et al. Liver fibrosis changes in HIV-HBV-coinfected patients: clinical, biochemical and histological effect of long-term Tenofovir disoproxil fumarate use. Antivir Ther. 2010;15:963–74.

Article  CAS  PubMed  Google Scholar 

Boyd A, Dezanet LNC, Kassime R, Miailhes P, Lascoux-Combe C, Chas J, et al. Subclinical and clinical outcomes in patients coinfected with HIV and chronic hepatitis B virus from clinical outpatient centers in france: protocol for an ambispective, longitudinal cohort study. JMIR Res Protoc. 2021;10:e24731.

Article  PubMed  PubMed Central  Google Scholar 

Lungu GN, Diaconescu GI, Dumitrescu F, Docea AO, Mitrut R, Giubelan L, Zlatian O et al. FibroScan((R)) versus biochemical scores: A study of liver fibrosis in HIV with HBV Co-Infection. Microorganisms. 2024;12.

Audsley J, Robson C, Aitchison S, Matthews GV, Iser D, Sasadeusz J, et al. Liver fibrosis regression measured by transient elastography in human immunodeficiency virus (HIV)-hepatitis B virus (HBV)-coinfected individuals on long-term HBV-active combination antiretroviral therapy. Open Forum Infect Dis. 2016;3:ofw035.

Article  PubMed  PubMed Central  Google Scholar 

Wei H, Song B. Elastography for longitudinal assessment of liver fibrosis after antiviral therapy: a review. J Clin Transl Hepatol. 2020;8:445–53.

Article  PubMed  PubMed Central  Google Scholar 

Park MS, Kim SU, Kim BK, Park JY, Kim DY, Ahn SH, et al. Prognostic value of the combined use of transient elastography and fibrotest in patients with chronic hepatitis B. Liver Int. 2015;35:455–62.

Article  PubMed  Google Scholar 

Benmassaoud A, Macias J, Delamarre A, Corma-Gomez A, Guaraldi G, Milic J, et al. Prognostic value of non-invasive scores based on liver stiffness measurement, spleen diameter and platelets in HIV-infected patients. Liver Int. 2023;43:1427–39.

Article  CAS  PubMed  Google Scholar 

Redd AD, Wendel SK, Grabowski MK, Ocama P, Kiggundu V, Bbosa F, et al. Liver stiffness is associated with monocyte activation in HIV-infected Ugandans without viral hepatitis. AIDS Res Hum Retroviruses. 2013;29:1026–30.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fung J, Lai CL, Seto WK, Yuen MF. The use of transient elastography in the management of chronic hepatitis B. Hepatol Int. 2011;5:868–75.

Article  PubMed  Google Scholar 

Liu J, Ma Y, Han P, Wang J, Liu YG, Shi RF, et al. Hepatic steatosis leads to overestimation of liver stiffness m